Michele Ly

1.1k total citations
16 papers, 166 citations indexed

About

Michele Ly is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Hepatology. According to data from OpenAlex, Michele Ly has authored 16 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 6 papers in Hepatology. Recurrent topics in Michele Ly's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Glioma Diagnosis and Treatment (4 papers) and Brain Metastases and Treatment (3 papers). Michele Ly is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Glioma Diagnosis and Treatment (4 papers) and Brain Metastases and Treatment (3 papers). Michele Ly collaborates with scholars based in United States, Mali and Germany. Michele Ly's co-authors include Ghassan K. Abou‐Alfa, Eileen M. O’Reilly, Joanne F. Chou, Maeve A. Lowery, Marinela Capanu, Richard Kinh Gian, James J. Harding, Imane El Dika, Leonard B. Saltz and Andrew Song and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and European Journal of Cancer.

In The Last Decade

Michele Ly

16 papers receiving 165 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Ly United States 6 50 47 44 44 42 16 166
Alexey Gurevich United States 7 44 0.9× 54 1.1× 40 0.9× 17 0.4× 16 0.4× 12 160
Angelo Dipasquale Italy 9 66 1.3× 15 0.3× 55 1.3× 36 0.8× 46 1.1× 23 217
Fiona E. Scott Australia 9 106 2.1× 23 0.5× 42 1.0× 33 0.8× 26 0.6× 23 221
Rosemary Millen Australia 9 85 1.7× 16 0.3× 48 1.1× 29 0.7× 29 0.7× 15 168
David Stroncek United States 4 83 1.7× 29 0.6× 87 2.0× 16 0.4× 42 1.0× 11 263
Daniel A. Wattson United States 5 60 1.2× 40 0.9× 46 1.0× 53 1.2× 31 0.7× 6 205
Nicolas Whenham Belgium 7 82 1.6× 79 1.7× 87 2.0× 64 1.5× 26 0.6× 17 234
V. Golfinopoulos Belgium 5 54 1.1× 14 0.3× 22 0.5× 69 1.6× 32 0.8× 10 182
Denise Lau United States 8 141 2.8× 46 1.0× 50 1.1× 63 1.4× 40 1.0× 19 191

Countries citing papers authored by Michele Ly

Since Specialization
Citations

This map shows the geographic impact of Michele Ly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Ly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Ly more than expected).

Fields of papers citing papers by Michele Ly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Ly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Ly. The network helps show where Michele Ly may publish in the future.

Co-authorship network of co-authors of Michele Ly

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Ly. A scholar is included among the top collaborators of Michele Ly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Ly. Michele Ly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Miller, C. Ryan, Andrew Song, Voichita Bar‐Ad, et al.. (2022). Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma. Frontiers in Oncology. 12. 896246–896246. 20 indexed citations
2.
Ly, Michele, et al.. (2021). Filling Gaps and Setting Boundaries: Examining Utilization of Health and Social services at JeffHOPE Student Run Clinics. Journal of Primary Care & Community Health. 12. 3667723100–3667723100. 2 indexed citations
3.
Miller, C. Ryan, Andrew Song, Voichita Bar‐Ad, et al.. (2021). Scalp-sparing radiation with concurrent temozolomide and tumor treating fields (SPARE) for patients with newly diagnosed glioblastoma.. Journal of Clinical Oncology. 39(15_suppl). 2056–2056. 3 indexed citations
4.
Song, Andrew, Voichita Bar‐Ad, Nina Martinez, et al.. (2020). Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma. Journal of Neuro-Oncology. 147(3). 653–661. 20 indexed citations
5.
Dika, Imane El, Marinela Capanu, Joanne F. Chou, et al.. (2020). Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib. Cancer Medicine. 9(20). 7453–7459. 12 indexed citations
6.
Connell, Louise C., Michele Ly, William R. Jarnagin, et al.. (2020). Hepatic arterial infusion (HAI) chemotherapy via the medtronic pump-assessing dose delivery, response rates and toxicity.. Journal of Clinical Oncology. 38(15_suppl). e16007–e16007. 1 indexed citations
8.
Maynard, Hannah, Zsofia K. Stadler, Michael F. Berger, et al.. (2020). Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings. Cancer. 126(9). 1995–2002. 33 indexed citations
9.
Song, Andrew, Michele Ly, Voichita Bar‐Ad, et al.. (2019). ACTR-49. INITIAL EXPERIENCE WITH SCALP PRESERVATION AND RADIATION PLUS CONCURRENT ALTERNATING ELECTRIC TUMOR-TREATING FIELDS (SPARE) FOR GLIOBLASTOMA PATIENTS. Neuro-Oncology. 21(Supplement_6). vi24–vi24. 2 indexed citations
10.
Harding, James J., Ghaith Abu‐Zeinah, Joanne F. Chou, et al.. (2018). Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma. Journal of the National Comprehensive Cancer Network. 16(1). 50–58. 39 indexed citations
11.
Frie, Kirstin Grosse, Bakarou Kamaté, C B Traoré, Michele Ly, & Eva Johanna Kantelhardt. (2018). Tackling Late-Stage Diagnosis of Breast Cancer Patients in Sub-Saharan Africa: A Case Study From Mali. Journal of Global Oncology. 4(Supplement 2). 64s–64s. 1 indexed citations
12.
Sissoko, Ibrahim, et al.. (2018). Management of Kidney Cancers in Urology Department of the Gabriel Toure University Hospital/Bamako. Surgical Science. 9(6). 183–188. 1 indexed citations
13.
Abou-Alfa, G.K., Jonghun Yoon, Manuel Modiano, et al.. (2016). An open-label, multi-center, phase I/II, dose escalation study of IV TKM-080301 in subjects with advanced hepatocellular carcinoma. European Journal of Cancer. 69. S22–S22. 3 indexed citations
15.
Abou‐Alfa, Ghassan K., Robert J. Mayer, David Cosgrove, et al.. (2015). Randomized phase II study of everolimus (E), leuprolide + letrozole (LL), and E + LL (ELL) in patients (pts) with unresectable fibrolamellar carcinoma (FLC).. Journal of Clinical Oncology. 33(15_suppl). e15149–e15149. 5 indexed citations
16.
Lowery, Maeve A., Eileen M. O’Reilly, James J. Harding, et al.. (2015). A phase I trial of binimetinib in combination with gemcitabine (G) and cisplatin (C) patients (pts) with untreated advanced biliary cancer (ABC).. Journal of Clinical Oncology. 33(15_suppl). e15125–e15125. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026